Schedule 13G ownership disclosure
Rich Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 76303T308
Event date: 2016-06-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 29,340,333
- Percent of class
- 954.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001078782-16-002945
- Form type
- SC 13G
- Filer
- LG CAPITAL FUNDING, LLC
- CIK
- CIK 1585346
- Filed
- Jun 06, 2016
- Reporting period
- Jun 02, 2016
- Description
- Schedule 13G beneficial ownership